Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04577833
Title A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC

prostate adenocarcinoma


Abiraterone + Niraparib + Prednisone

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | BEL

No variant requirements are available.